Opportunity Overview
On-site testing is mandatory. Any bid from a candidate who has not completed the tests will be deemed irregular. The site visit conditions are as follows: - laboratory tests may be carried out during weeks 45 and 46. - industrial tests may be carried out during weeks 48, 49, 50, and 51. This is a single-award framework agreement with no minimum amount but a maximum annual amount of €250,000 excluding VAT.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Communauté d'agglomération du Cotentin |
|---|---|
| Country | France |
| Category | Pharmaceuticals |
| Estimated value | $1.6M |
| CPV | 24300000 |
| Published | October 22, 2024 |
| Procurement stage | Active solicitation |
| Closed | January 15, 2025 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 06, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in France
See every France Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free France Pharmaceuticals intelligence report in your inbox
A personalized report on France Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.